We are live on ! Find out more
MVG

Madrona Venture Group Portfolio holdings

AUM $22.1M
1-Year Est. Return 86.9%
This Fund
S&P 500
This Quarter Est. Return
+79.1%
1 Year Est. Return
+86.9%
3 Year Est. Return
+233.1%
5 Year Est. Return
+22.16%
10 Year Est. Return
–
AUM
$22.1M
AUM Growth
+$8.22M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
12.7 quarters
Top 10 Avg Time Held
12.7 quarters
Top 20 Avg Time Held
12.7 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 54.84%
2 Technology 45.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NAUT icon
1
Nautilus Biotechnolgy
NAUT
$286M
$11.7M 53.24%
6,020,770
– –
2021 Q2
18 quarters
PATH icon
2
UiPath
PATH
$7.03B
$9.96M 45.16%
607,673
– –
2021 Q2
18 quarters
DNA icon
3
Ginkgo Bioworks
DNA
$875M
$353K 1.6%
42,430
– –
2025 Q2
2 quarters

Similar funds

Madrona Venture Group's Q4 2025 Portfolio in Review

As of Q4 2025, Madrona Venture Group held 3 positions worth $22.1M, up 59% from $13.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 0%. Madrona Venture Group opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 41% a quarter earlier, followed by Technology.

  • Madrona Venture Group's ten largest holdings make up 100% of its $22.1M portfolio in Q4 2025.
  • Madrona Venture Group opened 0 new positions and closed 0 in Q4 2025.
  • Madrona Venture Group's portfolio value rose 59% quarter-over-quarter to $22.1M.

Based on Madrona Venture Group's 13F filing for Q4 2025, filed 13 Feb 2026.